GSK
798 hedge funds and large institutions have $10.5B invested in GSK in 2018 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 222 increasing their positions, 310 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 4.42% → 4.45% (+0.03%)
5% less capital invested
Capital invested by funds: $11B → $10.5B (-$508M)
28% less repeat investments, than reductions
Existing positions increased: 222 | Existing positions reduced: 310
Holders
798
Holding in Top 10
17
Calls
$118M
Puts
$84.2M
Top Buyers
| 1 | +$117M | |
| 2 | +$76.4M | |
| 3 | +$66.2M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$65.5M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$65.2M |
Top Sellers
| 1 | -$118M | |
| 2 | -$56.5M | |
| 3 | -$48.3M | |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$40.8M |
| 5 |
Morgan Stanley
New York
|
-$39.7M |